A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

Clinical trial NCT00485836 · COMPLETED

Trial details

NCT number: NCT00485836
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Macular Edema Retinal Vein Occlusion

Start date: 2007-07-01
Primary completion: 2009-06-01
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.